Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NPM 1 Mutations in AML—The Landscape in 2023
Naman Sharma, Jane L. Liesveld
Cancers (2023) Vol. 15, Iss. 4, pp. 1177-1177
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

A 2024 Update on Menin Inhibitors. A New Class of Target Agents against KMT2A-Rearranged and NPM1-Mutated Acute Myeloid Leukemia
Anna Candoni, Gabriele Coppola
Hematology Reports (2024) Vol. 16, Iss. 2, pp. 244-254
Open Access | Times Cited: 21
Understanding mechanisms of resistance to FLT3 inhibitors in adult FLT3-mutated acute myeloid leukemia to guide treatment strategy
Martina Ruglioni, Stefania Crucitta, Giovanna Irene Luculli, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 201, pp. 104424-104424
Open Access | Times Cited: 11
Menin Inhibitors: New Targeted Therapies for Specific Genetic Subtypes of Difficult-to-Treat Acute Leukemias
Pasquale Niscola, Valentina Gianfelici, Marco Giovannini, et al.
Cancers (2025) Vol. 17, Iss. 1, pp. 142-142
Open Access | Times Cited: 1
XPO1/Exportin-1 in Acute Myelogenous Leukemia; Biology and Therapeutic Targeting
Øystein Bruserud, Frode Selheim, Maria Hernandez-Valladares, et al.
Biomolecules (2025) Vol. 15, Iss. 2, pp. 175-175
Open Access
Comprehensive biomarker profiles in hematological malignancies: improving diagnosis, prognosis, and treatment
Ali Golestan, Mohammadrasul Zareinejad, Amin Ramezani
Biomarkers in Medicine (2025), pp. 1-16
Closed Access
Variability in Expression of Homeobox Genes (HOXA9) and (HOXA7) in Acute Myeloid Leukemia Patients
Zainab Tallima, Dalia Ibraheem, Manal Wilson, et al.
Current Research in Translational Medicine (2025) Vol. 73, Iss. 2, pp. 103503-103503
Closed Access
Effect of NPM1 Mutation Subtype and Co‐Mutation Patterns on the Outcomes of Acute Myeloid Leukemia
Kittika Poonsombudlert, Ratdanai Yodsuwan, Sarah L. Mott, et al.
European Journal Of Haematology (2025)
Open Access
Mutations in the “hot spots” of the FLT3, NPM1, IDH1, IDH2 and DNMT3A genes in acute myeloid leukemia
Е. Н. Воропаева, М. В. Бурундукова, A. A. Lyzlova, et al.
Siberian Journal of Oncology (2025) Vol. 24, Iss. 1, pp. 125-141
Open Access
Maturation of small nucleolar RNAs: from production to function
Sarah Webster, Homa Ghalei
RNA Biology (2023) Vol. 20, Iss. 1, pp. 715-736
Open Access | Times Cited: 12
Pharmacokinetics and ADME Characterization After Oral and Intravenous Administration of [14C]‐Ziftomenib in Healthy Male Participants
Amitava Mitra, Julie Mackey Ahsan, Marilyn Tabachri, et al.
Clinical and Translational Science (2025) Vol. 18, Iss. 2
Open Access
IL1RAP is an immunotherapeutic target for normal karyotype triple-mutated acute myeloid leukemia
Arnaud Métois, Marie-Ève Bordeleau, Louis Thérêt, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Comprehensive Molecular Profiling of NPM1-Mutated Acute Myeloid Leukemia Using RNAseq Approach
Jessica Petiti, Ymera Pignochino, Aurora Schiavon, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3631-3631
Open Access | Times Cited: 3
Acute Myeloid Leukemia with NPM1 Mutation and Disseminated Leukemia Cutis: Achievement of Molecular Complete Remission by Venetoclax/Azacitidine Combination in a Very Old Patient
Pasquale Niscola, Carla Mazzone, Stefano Fratoni, et al.
Acta Haematologica (2023) Vol. 146, Iss. 5, pp. 408-412
Closed Access | Times Cited: 7
Nucleophosmin: A Nucleolar Phosphoprotein Orchestrating Cellular Stress Responses
Mohamed S. Taha, Mohammad Reza Ahmadian
Cells (2024) Vol. 13, Iss. 15, pp. 1266-1266
Open Access | Times Cited: 2
The Role of Epithelial-to-Mesenchymal Transition Transcription Factors (EMT-TFs) in Acute Myeloid Leukemia Progression
Diego Cuevas, Roberto Amigo, Adolfo Agurto, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1915-1915
Open Access | Times Cited: 2
Menin Inhibitors: New Players in KMT2A-Rearranged and NPM1-Mutated Acute Myeloid Leukemia
Gabriele Coppola, Anna Candoni
(2024)
Open Access | Times Cited: 1
Deciphering the Complexities of Acute Myeloid Leukemia: Emerging Roles of Epithelial to Mesenchymal Transition Transcription Factors (EMT-TFs) in Disease Progression
Diego Cuevas, Roberto Amigo, Adolfo Agurto, et al.
(2024)
Open Access | Times Cited: 1
Integrating holotomography and deep learning for rapid detection of NPM1 mutations in AML
Hyunji Kim, Geon Kim, HeyJung Park, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Clinical Significance of NPM1 A and Non A Mutations and Its Relation to The ARF/P53 Pathway in Egyptian Acute Myeloid Leukemia Patients
Samar S. Elshazly, Asmaa Abobakr, Hend A. Nooh
The Egyptian Journal of Hospital Medicine (2024) Vol. 94, Iss. 1, pp. 27-33
Open Access
Epigenenomic and transcriptomic characterization ofNPM1-mutated CN-AML subtypes
Lia N’Guyen, Clara Tellez-Quijorna, Julien Vernerey, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Human Leukocyte Antigen-DR and Cluster Designation 34: Double-negative Acute Myeloid Leukemias – Our Experience in Clinical Setting
Preeti Tripathi, Sanjeev Khera, Rajiv Kumar, et al.
Journal of Marine Medical Society (2024)
Open Access
Menin-mll protein-protein interaction inhibitors: a patent review (2021-present)
Fang Wang, Zhe Yang, Yujie Wu, et al.
Expert Opinion on Therapeutic Patents (2024), pp. 1-14
Closed Access
Cancer-Stem-Cell Phenotype-Guided Discovery of a Microbiota-Inspired Synthetic Compound Targeting NPM1 for Leukemia
Sergio Algar, Henar Vázquez‐Villa, Pedro Aguilar-Garrido, et al.
JACS Au (2024) Vol. 4, Iss. 5, pp. 1786-1800
Open Access
Comparative Analysis of AML Classification Systems: Evaluating the WHO, ICC, and ELN Frameworks and Their Distinctions
Huda Salman
Cancers (2024) Vol. 16, Iss. 16, pp. 2915-2915
Open Access
Molecular characteristics of NPM1 mutations in AML patients using targeted NGS
Reham Abo Elwafa, Magdy El-Bordiny, Ashraf Elghandour, et al.
Alexandria Journal of Medicine (2024) Vol. 60, Iss. 1, pp. 259-264
Open Access
Page 1 - Next Page

Scroll to top